Patient-Reported Outcomes After Structural Autograft for Large or Cystic Talar Dome Osteochondral Lesions.
Adult
Arthroscopy
Bone Cysts
/ surgery
Bone Diseases
/ surgery
Bone Transplantation
/ methods
Cartilage Diseases
/ surgery
Cartilage, Articular
/ transplantation
Female
Humans
Male
Middle Aged
Pain Measurement
Patient Reported Outcome Measures
Talus
/ surgery
Tibia
/ transplantation
Transplantation, Autologous
ankle arthroscopy
bone grafting
microfracture
osteochondral autograft transfer system
osteochondral defect
osteochondral grafting
talar osteochondral lesion
Journal
Foot & ankle international
ISSN: 1944-7876
Titre abrégé: Foot Ankle Int
Pays: United States
ID NLM: 9433869
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
25
2
2020
medline:
21
7
2021
entrez:
25
2
2020
Statut:
ppublish
Résumé
While smaller talar dome osteochondral lesions (OCLs) are successfully treated with bone marrow stimulation techniques, the optimal treatment for large or cystic OCLs remains controversial. This study tested the hypothesis that transferring structural autograft bone from the distal tibia to the talus for large or cystic OCLs improves pain and function. Thirty-two patients with large or cystic OCLs underwent structural bone grafting from the ipsilateral distal tibia to the talar dome. Patients were assessed with subjective patient-centered tools and objective clinical outcomes. Average age was 48.6 ± 14.9 years, and average follow-up was 19.5 ± 13.3 months. Average lesion area was 86.2 ± 23.5 mm At final follow-up, improvement compared to preoperative scores was seen in American Orthopaedic Foot & Ankle Society (65.4 ± 21.2 to 86.9 ± 15.0, This study demonstrates that structural bone graft harvested from the distal tibia transferred to the talus was a safe and effective treatment for large and cystic OCLs. Outcomes compare favorably to other described techniques for treatment of these injuries. Level IV, case series.
Sections du résumé
BACKGROUND
While smaller talar dome osteochondral lesions (OCLs) are successfully treated with bone marrow stimulation techniques, the optimal treatment for large or cystic OCLs remains controversial. This study tested the hypothesis that transferring structural autograft bone from the distal tibia to the talus for large or cystic OCLs improves pain and function.
METHODS
Thirty-two patients with large or cystic OCLs underwent structural bone grafting from the ipsilateral distal tibia to the talar dome. Patients were assessed with subjective patient-centered tools and objective clinical outcomes. Average age was 48.6 ± 14.9 years, and average follow-up was 19.5 ± 13.3 months. Average lesion area was 86.2 ± 23.5 mm
RESULTS
At final follow-up, improvement compared to preoperative scores was seen in American Orthopaedic Foot & Ankle Society (65.4 ± 21.2 to 86.9 ± 15.0,
CONCLUSION
This study demonstrates that structural bone graft harvested from the distal tibia transferred to the talus was a safe and effective treatment for large and cystic OCLs. Outcomes compare favorably to other described techniques for treatment of these injuries.
LEVEL OF EVIDENCE
Level IV, case series.
Identifiants
pubmed: 32088985
doi: 10.1177/1071100720907313
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM